| Nov 6 |
Rhythm Pharmaceuticals, Inc. 2024 Q3 - Results - Earnings Call Presentation
|
| Nov 5 |
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q3 Loss, Tops Revenue Estimates
|
| Nov 5 |
Rhythm Pharmaceuticals GAAP EPS of -$0.73 beats by $0.08, revenue of $33.25M beats by $0.78M
|
| Nov 5 |
Rhythm Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Update
|
| Nov 4 |
Rhythm Pharmaceuticals Q3 2024 Earnings Preview
|
| Nov 4 |
Rhythm Pharmaceuticals Announces Five New Data Presentations at ObesityWeek® 2024
|
| Oct 31 |
Will Allogene Therapeutics (ALLO) Report Negative Earnings Next Week? What You Should Know
|
| Oct 29 |
Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
|
| Oct 28 |
ImmunityBio (IBRX) Soars 26.4%: Is Further Upside Left in the Stock?
|
| Oct 24 |
Rhythm Pharmaceuticals and Axovia Therapeutics Announce Joint Research Collaboration in Bardet-Biedl Syndrome
|
